Overview

Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease

Status:
Unknown status

Trial end date:
2018-06-01

Target enrollment:

Participant gender:

Summary

This study is designed to evaluate the feasibility and diagnostic performance of a novel rapid regadenoson stress CMR protocol for detecting of obstructive coronary artery disease.

Phase:

Phase 4

Details

Lead Sponsor:

Dipan Shah

Collaborator:

Astellas Pharma Global Development, Inc.

Treatments:

Regadenoson